MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
15.35
+1.11 (7.79%)
At close: Sep 18, 2025, 4:00 PM EDT
15.05
-0.30 (-1.95%)
After-hours: Sep 18, 2025, 7:31 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $69.43 million as of September 18, 2025. Its market cap has increased by 116.78% in one year.
Market Cap
69.43M
Enterprise Value
73.68M
1-Year Change
116.78%
Ranking
Category
Stock Price
$15.35
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $69.43M, a decrease of -82.03%. That is a compound annual growth rate of -35.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 64.41M | 133.20% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |